Dysaesthetic penoscrotodynia: Nomenclature, classification, diagnosis and treatment

International Journal of STD and AIDS

Volumn 22, Issue 9, 2011, Pages 483-487

  Markos, A R ^a  

^a Mid Staffordshire General Hospitals NHS Trust   (United Kingdom)

Author keywords

Classification; Dysaesthetic penoscrotodynia; Male genital pain; Nomenclature; Penodynia; Scrotodynia

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; STEROID;

ALCOHOL INDUCED PENODYNIA; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; CAFFEINE INDUCED GENITAL SKIN PAIN; COGNITIVE THERAPY; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DYSESTHESIA; DYSESTHETIC PENOSCROTODYNIA; GENITAL PAIN; GENITAL SYSTEM DISEASE; HUMAN; PATCH TEST; PATIENT CARE; PENOSCOPY; PREVALENCE; PRIORITY JOURNAL; RED SCROTUM SYNDROME; RESTLESS GENITAL SYNDROME; REVIEW; SCROTUM DISORDER; SKIN BIOPSY; SKIN BURNING SENSATION; SKIN TEST; STEROID THERAPY; TRANSCUTANEOUS NERVE STIMULATION; VULVODYNIA;

GENITAL DISEASES, MALE; HUMANS; MALE; PENILE DISEASES; SCROTUM; TERMINOLOGY AS TOPIC;

EID: 80052505824     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2011.010451     Document Type: Review

References (46)

1. Markos AR. Genital pain of unknown aetiology. Int J STD AIDS 2002;13:215
2. Markos AR. The male genital skin burning syndrome (Dysaesthetic Peno/ Scroto-dynia). Int J STD AIDS 2002;13:271-272
3. Markos AR. Alcohol-induced peno-dynia. Int J STD AIDS 2004;15:49
4. Ehlers I, Hipler UC, Zuberbier T, et al. Ethanol as a cause of hypersensitivity reactions to alcoholic beverages. Clin Exp Allergy 2002;328:1231-1235
5. Boehncle WH, Gall H. Ethanol metabolite acetic acid as causative agent for type-1 hypersensitivity like reactions to alcoholic beverages. Clin Exp Allergy 1996;26:1089-1091
6. Trevisani M, Smart D, Gunthorpe MJ, et al. Ethanol elicits and potentiates nociceptor responses via the vanilloid receptor-1. Nature Neuroscience 2002;5:545-551
7. Markos AR. Caffeine-related genital skin pain. J Low Genit Tract Dis 2008;12:38-39
8. Esser MJ, Chase T, Allen GV, et al. Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions. Eur J Pharmacol 2001;430:211-218
9. Esser MJ, Sawynok J. Caffeine blockade of the thermal antihyperalgesic effect of acute amitriptyline in a rat model of neuropathic pain. Eur J Pharmacol 2000;99:131-139
10. Lynch PJ, Edwards L. Penile and scrotal pain. In: Lynch PJ, Edward L (eds). Genital Dermatology. New York: Churchill Livingstone, 1994:247-248
11. Fisher BK. The red scrotum syndrome. Cutis 1997;60:139-141
12. Prevost N, English JC. Red scrotal syndrome: a localized phenotypical expression of erythromelalgia. J Drugs Dermatol 2007;6:935-936
13. Heidrich H. Functional vascular diseases: Raynaud's syndrome, acrocyanosis and erythromelalgia. VASA 2010;39:33-41
14. Cohen JS. Erythromelalgia: new theories and new therapies. J Am Acad Dermatol 2000;43:841-847
15. Updike GM, Wiesenfeld HC. Insight into the treatment of vulvar pain: a survey of clinicians. Am J Obstet Gynecol 2005;193:1404-1409
16. Goldstein AT, Marinott SC, Haefner HK. Vulvodynia: strategies for treatment. Clin Obstet Gynecol 2005;48:769-785
17. Waldinger MD, Venema PL, van Gils AP, et al. Stronger evidence for small fiber sensory neuropathy in restless genital syndrome: two case reports in males. J Sex Med 2011;8:325-330
18. Harlow BL, He W, Nguyen RI. Allergic reactions and risk of vulvodynia. Ann Epidermal AEP 2009;19:771-777
19. Helton J, Storrs F. The burning mouth syndrome: lack of a role for contact urticaria and contact dermatitis. J Am Acad Dermatol 1994;31(Pt 1):201-205
20. Machet L, Le Du S, Bernez A, et al. The value of allergy survey in a retrospective series of 40 patients with burning-mouth syndrome (Stomatodynia). Ann Dermatol Venereol 2008;135:105-109
21. Turner-Cobb JM, Osborn M, da Silva L, et al. Sex differences in hypothalamic pituitary-adrenal axis function, in patients with chronic pain syndrome. Stress 2010;13:292-300
22. Deval E, Gasull X, Noel J, et al. Acid-sensing ion channels (ASICs): pharmacology and implication in pain. Pharmacol Ther 2010;128:549
23. Haefner HK. Report of the International Society for the Study of Vulvovaginal Disease terminology and classification of Vulvodynia. J Low Genit Tract Dis 2007;11:48-49
24. Mancuso G, Berdondini RM. Simultaneous occurrence of dysaesthetic peno/ scroto-dynia and stomatodynia. Int J STD AIDS 2005;16:830-831
25. Gaitonde P, Rostron J, Longman L, et al. Burning mouth syndrome and vulvodynia coexisting in the same patient: a case report. Dent Update 2002;29:75-76
26. Harlow BL, Stewart EG. A population-based assessment of chronic unexplained vulvar pain: have we underestimated the prevalence of vulvodynia? J Am Med Womens Assoc 2003;58:82-88
27. Reed BD, Crawford S, Couper M. Pain at the vulvar vestibule: a web based survey. J Low Genit Tract Dis 2004;8:48-57
28. Gordon AS, Panahian-Jand F, et al. Characteristics of women with vulvar pain disorders: responses to a Web-bases survey. J Sex Marital Ther 2003;29:45-58
29. Arnold LD, Bachmann GA, Rosen R, et al. Assessment of vulvodynia symptoms in a sample of US women: a prevalence survey with a nested case control study. Am J Obstet Gynecol 2007;196:128.e1-e6
30. Ehrstróm S, Kornfeld D, Rylander E, et al. Chronic stress in women with localised provoked vulvodynia. J Psychosom Obstet Gynaecol 2009;30:73-79
31. Desrochers G, Bergeron S, Khalifé S, et al. Provoked vestibulodynia: psychological predictors of topical and cognitive-behavioral treatment outcome. Behav Res Ther 2010;48:106-115
32. Ferrari R, Russell AS. Effect of a symptom diary on symptom frequency and intensity in healthy subjects. J Rheumatol 2010;37:2387-2389
33. Regauer S, Eberz B. Diagnosis and management of vulvodynia should include biopsy and histological examination. Br J Dermatol 2010;103:663-665
34. Goetsch MF, Morgan TK, Korcheva VB, et al. Histologic and receptor analysis of primary and secondary vestibulodynia and controls: a prospective study. Am J Obstet Gynecol 2010;202:614:e1-e8
35. Dennerstein GJ. Diagnosis and treatment of vulvodynia. J Reprod Med 2009;54:529
36. Danby CS, Margesson LJ. Approach to the diagnosis and treatment of vulvar pain. Dermatol Ther 2010;23:485-504
37. Green J, Christmas P, Goldmeier D, et al. A review of physical and psychological factors in vulvar vestibulitis syndrome. Int J STD AIDS 2001;12:705-709
38. Petersen CD, Lundvall L, Kristensen E, et al. Vulvodynia. Definition, diagnosis and treatment. Acta Obstet Gynecol Scand 2008;87:893-901
39. Zolnoun DA, Rohl J, Moore CG, et al. Overlap between orofacial pain and vulvar Vestibulitis syndrome. Clin J Pain 2008;24:187-191
40. Sawynok J, Esser MJ, Reaid AR. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat. Pain 1999;82:149-58
41. Matsuzawa-Yanagida K, Narita M, Nakajima M, et al. Usefulness of antidepressants for improving the neuropathic pain-like state and pain-induced anxiety through actions at different brain sites. Neuro-psychopharmacology 2008;33:1952-1965
42. Mochizucki D. Serotonin and nor-adrenaline reuptake inhibitors in animal models of pain. Hum Psychopharmacol 2004;19(Suppl 1):S15-S19
43. O'Connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 2009;122(Suppl):S22-S32
44. Dworkin RH, O'Connor AB, Audette J, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc 2010;85(Suppl):S3-S14
45. Murina F, Bianco V, Radici G, et al. Transcutaneous electrical nerve stimulation to treat vestibulodynia: a randomised controlled trial. BJOG 2008;115:1165-1170
46. Murina F, Bianco V, Radici G, et al. Electro-diagnostic functional sensory evaluation of patients with generalized vulvodynia: a pilot study. J Low Genit Tract Dis 2010;14:221-224